Effect of Formulation Variables on the Floating Properties of Gastric Floating Drug Delivery System

ABSTRACT Purpose. To evaluate the contribution of formulation variables on the floating properties of a gastric floating drug delivery system (GFDDS) using a continuous floating monitoring system and statistical experimental design. Methods. A modified continuous floating monitoring system, which consisted of an electric balance interfacing with a PC, was designed to perform the continuous monitoring of floating kinetics of GFDDS. Several formulation variables, such as different types of hydroxypropyl methylcellulose (HPMC), varying HPMC/Carbopol ratio, and addition of magnesium stearate, were evaluated using Taguchi design, and the effects of these variables were subjected to statistical analysis. Results. The continuous floating monitoring system developed was validated, using capsules with different density, and a good correlation between theoretical and experimental values was obtained (R2 = 0.9998), indicating the validity of the setup. The statistical analysis indicated that magnesium stearate had a significant effect on the floating property of GFDDS (p<0.05), and addition of magnesium stearate could significantly improve the floating capacity of the GFDDS. It was found that the HPMC of higher viscosity grade generally exhibited a greater floating capacity, but the effect was not statistically significant. For polymers with the same viscosity, i.e., K4M and E4M, the degree of substitution of the function group did not show any significant contribution. A better floating behavior was achieved at higher HPMC/Carbopol ratio. Carbopol appeared to have a negative effect on the floating behavior of GFDDS. Conclusions. It was concluded that by using a validated continuous floating monitoring system, the effect of formulation variables on the floating property of the delivery system and their ranges could be identified. Incorporation of hydrophobic agents, such as magnesium stearate, could significantly improve the floating capacity of the GFDDS.

[1]  E. Frei,et al.  Study of gastric emptying using a ferromagnetic tracer. , 1977, Gastroenterology.

[2]  Nikolaos A. Peppas,et al.  PREPARATION, STRUCTURE AND DIFFUSIONAL BEHAVIOR OF HYDROGELS IN CONTROLLED RELEASE , 1993 .

[3]  O. Güven,et al.  Formulation and in Vitro–in Vivo Evaluation of Buccoadhesive Morphine Sulfate Tablets , 1994, Pharmaceutical Research.

[4]  J. Robinson,et al.  In vivo swelling kinetics of a series of hydrogel polymers in the cannulated gastrointestinal tract of the canine , 1997 .

[5]  R. Khar,et al.  Measurement of bioadhesive strength of muco-adhesive buccal tablets: design of an in-vitro assembly , 1993 .

[6]  A. Moës.  Gastroretentive dosage forms. , 1993, Critical reviews in therapeutic drug carrier systems.

[7]  J. Timmermans,et al.  Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. , 1994, Journal of pharmaceutical sciences.

[8]  R. Siegel.  Hydrophobic weak polyelectrolyte gels: Studies of swelling equilibria and kinetics , 1993 .

[9]  I. Kellaway,et al.  Influence of glycerol concentration and carbopol molecular weight on swelling and drug release characteristics of metoclopramide hydrogels , 1994 .

[10]  Kinam Park,et al.  Gastric retentive drug-delivery systems. , 1998, Critical reviews in therapeutic drug carrier systems.

[11]  F. Bronner,et al.  Intestinal calcium absorption: mechanisms and applications. , 1987, The Journal of nutrition.

[12]  Y. Chien,et al.  Oral mucosa controlled delivery of LHRH by bilayer mucoadhesive polymer systems , 1995 .

[13]  Christopher T. Rhodes,et al.  Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application , 1994 .

[14]  S. Agarwal,et al.  PREPARATION AND EVALUATION OF MUCO-ADHESIVE BUCCAL FILMS OF CLOTRIMAZOLE FOR ORAL CANDIDA INFECTIONS , 1997 .

[15]  Sanford Bolton,et al.  A Floating Controlled-Release Drug Delivery System: In Vitro-in Vivo Evaluation , 1993, Pharmaceutical Research.

[16]  P. Dallas,et al.  FLOATING AND SWELLING CHARACTERISTICS OF VARIOUS EXCIPIENTS USED IN CONTROLLED RELEASE TECHNOLOGY , 1993 .

[17]  R. Kaune.  Mechanisms of intestinal calcium absorption and availability of dietary calcium in pigs. , 1996, DTW. Deutsche tierarztliche Wochenschrift.